NMR
Nomura Holdings Inc
9.80$
-1.8%
vs. previous close
Closing price · As of: Aug 14, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -0.1% | +0.7% | +8.3% | -3.8% | +5.3% | -6.2% | +2.3% | +3.9% | +2.6% | +1.1% | +8.9% | |
| – | +6.1% | -1.5% | -9.0% | +20.6% | +353.9% | -79.0% | +567.8% | -17.6% | +27.8% | +16.9% | -31.0% | |
| – | +4.8% | +0.8% | -6.8% | +20.5% | -3.7% | -1.1% | +9.7% | +13.0% | -12.2% | -28.3% | +43.3% | |
| – | +4.8% | +0.8% | -6.8% | +20.5% | +404.4% | -81.1% | +684.2% | -19.9% | +31.2% | -89.0% | +598.8% | |
| – | +10.4% | -8.2% | -14.5% | +2.8% | +235.8% | -67.0% | +188.0% | +3.0% | +4.3% | -64.6% | +220.3% | |
| – | +5.8% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +5.7% | -7.0% | -4.9% | +6.6% | +16.7% | – | – | |
| – | – | +0.0% | – | – | – | – | – | – | – | – | – | |
| – | +0.3% | -53.4% | – | – | – | – | – | – | – | – | – | |
| – | -0.1% | +0.6% | +8.7% | -3.8% | +5.2% | -6.4% | +2.4% | +4.1% | +2.4% | +1.2% | +9.3% | |
| – | -0.3% | -4.3% | +10.1% | -4.4% | +12.7% | -13.8% | +2.4% | +4.4% | -1.7% | +16.7% | +3.3% | |
| – | +0.8% | -9.5% | +10.7% | -5.1% | -5.5% | -2.2% | -4.0% | +0.9% | -0.7% | -89.5% | +929.4% | |
| – | +8.8% | -9.3% | +8.8% | -9.5% | +11.6% | -4.3% | +12.2% | +33.0% | -26.3% | +5.5% | +18.5% | |
| – | +5.7% | +6.2% | +5.8% | -1.0% | +7.1% | -4.5% | +3.7% | +3.5% | +3.4% | +4.2% | +7.6% | |
| – | -0.4% | +2.2% | +3.4% | -4.7% | +8.2% | -2.8% | +0.1% | +0.3% | +4.8% | +1.5% | +3.4% | |
| – | +3.1% | +0.7% | +3.4% | +1.7% | +5.7% | -1.5% | +5.1% | +0.7% | +4.6% | -2.6% | +6.9% | |
| – | -0.1% | +0.3% | -2.0% | -1.1% | +0.5% | +0.3% | -0.2% | -1.7% | +0.4% | +0.4% | -1.1% |
Data as of: August 14, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.